Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension (PAH).

pulmonary hypertension

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 01 November 2013 - 09:09 AM

Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension (PAH).

 

Our systematic review revealed that most evidence exists for transthoracic echocardiogram (TTE), pulmonary function tests, and NT-ProBNP for screening and diagnosis of systemic sclerosis-PAH; however, more robust studies are needed. PubMed, Semin Arthritis Rheum. 2013 Sep 5. (Also see: Pulmonary Hypertension Diagnosis)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)